The Acute Lung Injury Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Acute Lung Injury Market?
The market size for acute lung injury has consistently expanded over the past few years. Between 2024 and 2025, the market size is predicted to increase from $2.48 billion to $2.60 billion, representing a compound annual growth rate (CAGR) of 4.7%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Acute Lung Injury Industry?
The Acute Lung Injury Global Market is projected to reach a market size of $3.09 billion in 2029, with a compound annual growth rate (CAGR) of 4.4%.
Download Your Free Sample of the 2025 Acute Lung Injury Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Acute Lung Injury Market?
The key drivers in the acute lung injury market are:
•The advancement and application of biologics and gene therapies
•Availability of government funding and grants
•Development and implementation of precision and regenerative medicine, including stem cell therapies
•Ongoing global health policy reforms
Global Market Segmentation: Identifying Major Acute Lung Injury Industry Segments
The acute lung injury market covered in this report is segmented –
1) By Injury Type: Direct Injury, Indirect Injury
2) By Therapy: Mechanical Ventilation, Pharmacotherapy, Fluid Management, Other Therapies
3) By End User: Hospitals, Clinics, Other End Users
Subsegments:
1) By Direct Injury: Trauma-Induced Acute Lung Injury, Aspiration Pneumonitis, Pneumonia-Related Acute Lung Injury, Inhalation Injury
2) By Indirect Injury: Sepsis-Related Acute Lung Injury, Shock-Induced Acute Lung Injury, Acute Lung Injury Due To Blood Transfusion, Acute Lung Injury Associated With Pancreatitis
Pre-order the 2025 Acute Lung Injury Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Acute Lung Injury Market?
The key trends in the acute lung injury market are:
•The development of biologic drugs is a significant emerging trend.
•Wearable and remote monitoring devices are increasingly shaping the future of the market.
•The adoption of inhalation-based therapies is becoming prevalent.
•There is a growing trend towards the integration of CRISPR and gene editing technologies and biosensors for real-time analysis.
Who Are the Top Competitors & Leading Players in the Acute Lung Injury Market?
Major players in the acute lung injury market are:
• Thermo Fisher Scientific Inc.
• GlaxoSmithKline plc
• Medtronic plc
• Baxter International Inc.
• Ono Pharmaceutical Co Ltd.
• Aster DM Healthcare
• Octapharma AG
• Cartesian Therapeutics Inc.
• Vapotherm Inc.
• Stemedica Cell Technologies Inc.
• Implicit Bioscience Ltd.
• Apeiron Biologics AG
• Faron Pharmaceuticals Ltd.
• Histocell Sociedad Limitada
• Vasomune Therapeutics Inc
• Windtree Therapeutics Inc.
• Qx Therapeutics Inc.
• Asklepion Pharmaceuticals LLC
• ReAlta Life Sciences Inc.
• MediciNova Inc.
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the acute lung injury market in 2024
